PT - JOURNAL ARTICLE AU - Riley CC Brown AU - Jeff S Coombes AU - Klaus Jungbluth Rodriguez AU - Ingrid J Hickman AU - Shelley E Keating TI - Effectiveness of exercise via telehealth for chronic disease: a systematic review and meta-analysis of exercise interventions delivered via videoconferencing AID - 10.1136/bjsports-2021-105118 DP - 2022 Jun 16 TA - British Journal of Sports Medicine PG - bjsports-2021-105118 4099 - http://bjsm.bmj.com/content/early/2022/06/16/bjsports-2021-105118.short 4100 - http://bjsm.bmj.com/content/early/2022/06/16/bjsports-2021-105118.full AB - Objective To investigate the effectiveness of videoconferencing exercise interventions for people with chronic diseases.Design Systematic review incorporating meta-analysis.Data sources PubMed, Cinahl, MEDLINE, Web of Science, Embase and Scopus.Eligibility criteria The current literature was searched following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Trials analysing participants with chronic disease undergoing aerobic and/or resistance exercise training over videoconferencing, with exercise capacity and/or quality of life outcomes were included. Meta-analyses were conducted for between-group comparisons of exercise capacity and quality of life. Risk of bias was analysed using the Downs and Black quality checklist and the certainty of evidence with Grading of Recommendations, Assessment, Development and Evaluation (GRADE).Results Thirty-two trials were included in this review, of which 12 were comparator trials. Small–moderate between-group (videoconferencing vs comparator) effects favouring videoconferencing were seen for studies using a non-exercising comparator for exercise capacity (standardised mean difference (SMD)=0.616, 95% CI 0.278 to 0.954; p=<0.001) and quality of life (SMD=0.400, 95% CI 0.099 to 0.701; p=0.009). Small effects favouring videoconferencing were observed for studies using an exercising comparator for quality of life (SMD=0.271, 95% CI 0.028 to 0.515; p=0.029) and exercise capacity (SMD=0.242, 95% CI 0.059 to 0.426; p=0.009). Moderate risk of bias was identified for included studies (16.3±3.6/28), with GRADE certainty ratings of ‘low’ (quality of life) and ‘moderate’ (exercise capacity). Session attendance was 70% and was reported in 23 trials. No serious adverse events relating to videoconferencing were found. Nine trials documented the total number of technical issues that occurred in 17% of the sessions. Positive satisfaction outcomes were associated with ease of access and usefulness of technology.Conclusion In patients with chronic disease, videoconferencing exercise interventions appear to be feasible and effective for improving exercise capacity and quality of life. More robust methodology is needed in future studies to improve the certainty of the evidence.PROSPERO registration number CRD42020191243.